http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103665384-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c6ed83b9d5c28c6c356d1d08d58501e7
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G81-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G63-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G63-91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G73-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
filingDate 2013-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d3cb8508a58baf647c2cd71cff16fb8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f39aaec385f159848d6b961ff77115f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88a21c117a00505e51c0f4d9f6ce6b04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46904ad8c179b81dbed334c268e24ad1
publicationDate 2014-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103665384-A
titleOfInvention Preparation method and application of novel cationic graft copolymer and multiple composite non-viral gene carrier
abstract The invention relates to a preparation method and application of a novel cationic graft copolymer and a multi-composite non-viral gene carrier. A novel cationic graft copolymer polycaprolactone-g-L polyethyleneimine (PCL-g-LPEI) was synthesized by ring-opening copolymerization and amidation reaction. The composition of its multiplex non-viral gene carrier includes: (A) plasmid DNA The polycaprolactone-g-L polyethyleneimine cationic complex acts as the core of the multiple gene complex; (B) the tumor-targeting ligand hyaluronic acid (HA) wraps the cationic complex through positive and negative charge interactions as the multiple gene complex Composite shell. The multiple compound gene constructed by this new type of non-viral gene carrier has the advantages of low cytotoxicity, good blood compatibility, high transfection efficiency, tumor targeting effect, etc., and is expected to be applied in clinical gene therapy.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113045682-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020182226-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109646681-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11559477-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105999310-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107722284-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108553650-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107722284-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109550057-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106924746-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112898579-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112898579-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106801068-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108553650-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114470237-A
priorityDate 2013-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101239283-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465793305
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164001263

Total number of triples: 38.